{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:57Z","timestamp":1707524157067},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,1,21]]},"DOI":"10.7759\/cureus.12839","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T17:56:12Z","timestamp":1611251772000},"source":"Crossref","is-referenced-by-count":0,"title":["Frequency of Cardiovascular Manifestation in Patients With Hyperthyroidism"],"prefix":"10.7759","author":[{"given":"Naresh Kumar","family":"Khurana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sameet","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pardeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Rizwan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Hyperthyroidism: diagnosis and treatment","volume":"93","author":"Kravets I","year":"2016","unstructured":"Kravets I. Hyperthyroidism: diagnosis and treatment. Am Fam Physician. 2016, 93:363-70.","journal-title":"Am Fam Physician"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3923\/jms.2002.89.94","article-title":"Thyroid disorders, etiology and prevalence","volume":"2","author":"Khan A","year":"2002","unstructured":"Khan A, Muzaffar Khan MMA, Akhtar S. Thyroid disorders, etiology and prevalence. J Med Sci. 2002, 2:89-94. 10.3923\/jms.2002.89.94","journal-title":"J Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12816","article-title":"Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters","volume":"84","author":"Goichot B","year":"2015","unstructured":"Goichot B, Caron P, Landron F, Bou\u00e9e S. Clinical presentation of hyperthyroidism in a large representative sample of outpatients in France: relationships with age, aetiology and hormonal parameters. Clin Endocrinol. 2015, 84:445-51. 10.1111\/cen.12816","journal-title":"Clin Endocrinol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.emc.2013.12.001","article-title":"Hyperthyroidism and thyrotoxicosis","volume":"32","author":"Devereaux D","year":"2014","unstructured":"Devereaux D, Tewelde SZ. Hyperthyroidism and thyrotoxicosis. Emerg Med Clin North Am. 2014, 32:277-92. 10.1016\/j.emc.2013.12.001","journal-title":"Emerg Med Clin North Am"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2495","article-title":"Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study","volume":"95","author":"Boelaert K","year":"2010","unstructured":"Boelaert K, Torlinska B, Holder RL, Franklyn JA. Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab. 2010, 95:2715-26. 10.1210\/jc.2009-2495","journal-title":"J Clin Endocrinol Metab"},{"key":"ref6","article-title":"Hyperthyroidism: a stepwise approach to treatment","volume":"60","author":"Ghandour A","year":"2011","unstructured":"Ghandour A, Reust C. Hyperthyroidism: a stepwise approach to treatment. J Fam Pract. 2011, 60:388-95.","journal-title":"J Fam Pract"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00108-008-2155-3","article-title":"Prevention and multimodal therapy of hyperthyroidism [Article in German]","volume":"49","author":"Palitzsch KD","year":"2008","unstructured":"Palitzsch KD. Prevention and multimodal therapy of hyperthyroidism [Article in German]. Internist. 2008, 49:1428-36. 10.1007\/s00108-008-2155-3","journal-title":"Internist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1161\/01.str.19.1.15","article-title":"Stroke in thyrotoxicosis with atrial fibrillation","volume":"19","author":"Petersen P","year":"1988","unstructured":"Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke. 1988, 19:15-8. 10.1161\/01.str.19.1.15","journal-title":"Stroke"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.5114\/aoms.2013.38685","article-title":"Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology","volume":"9","author":"Ertek S","year":"2013","unstructured":"Ertek S, Cicero AF. Hyperthyroidism and cardiovascular complications: a narrative review on the basis of pathophysiology. Arch Med Sci. 2013, 9:944-52. 10.5114\/aoms.2013.38685","journal-title":"Arch Med Sci"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1210\/endo.137.3.8603588","article-title":"Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart","volume":"137","author":"Ojamaa K","year":"1996","unstructured":"Ojamaa K, Klemperer JD, MacGlivray SS, Klein I, Samarel A. Thyroid hormone and hemodynamic regulation of beta-myosin heavy chain promoter in the heart. Endocrinology. 1996, 137:802-8. 10.1210\/endo.137.3.8603588","journal-title":"Endocrinology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(90)90530-q","article-title":"Biochemical basis of thyroid hormone action in the heart","volume":"88","author":"Dillman WH","year":"1990","unstructured":"Dillman WH. Biochemical basis of thyroid hormone action in the heart. Am J Med. 1990, 88:626-30. 10.1016\/0002-9343(90)90530-q","journal-title":"Am J Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.75.2.245","article-title":"Thyroid hormone-induced alteration in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation","volume":"75","author":"Kiss E","year":"1994","unstructured":"Kiss E, Jakab G, Kranias EG, Edes I. Thyroid hormone-induced alteration in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. Circ Res. 1994, 75:245-51. 10.1161\/01.res.75.2.245","journal-title":"Circ Res"},{"key":"ref13","article-title":"Hyperthyroidism and the heart","volume":"49","author":"Panagoulis C","year":"2008","unstructured":"Panagoulis C, Halapas A, Chariatis E, Driva P, Matsakas E. Hyperthyroidism and the heart. Hellenic J Cardiol. 2008, 49:169-75.","journal-title":"Hellenic J Cardiol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.abb.2008.04.019","article-title":"Effect of thyroid hormone on the distribution and activity of Na, K-ATPase in ventricular myocardium","volume":"475","author":"Kasturi S","year":"2008","unstructured":"Kasturi S, Ismail-Beigi F. Effect of thyroid hormone on the distribution and activity of Na, K-ATPase in ventricular myocardium. Arch Biochem Biophys. 2008, 475:121-7. 10.1016\/j.abb.2008.04.019","journal-title":"Arch Biochem Biophys"},{"key":"ref15","article-title":"Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity? [Article in Danish]","volume":"55","author":"Toft P","year":"1993","unstructured":"Toft P, B\u00f8tker HE. Hyperthyroidism and heart disease. Is thyrotoxic cardiomyopathy a disease entity? [Article in Danish]. Ugeskr Laeger. 1993, 55:1354-7.","journal-title":"Ugeskr Laeger"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.18203\/2320-6012.ijrms20161999","article-title":"Cardiovascular manifestation in hyperthyroidism","volume":"4","author":"Kandan V","year":"2017","unstructured":"Kandan V, Sathyamurthy P, Rajkumar M, Narayanan L. Cardiovascular manifestation in hyperthyroidism. J Res Med Sci. 2017, 4:3032-8. 10.18203\/2320-6012.ijrms20161999","journal-title":"J Res Med Sci"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.5144\/0256-4947.2000.485","article-title":"Clinical and endocrine aspects of thyrotoxicosis and its cardiovascular complications","volume":"20","author":"Zargar AH","year":"2000","unstructured":"Zargar AH, Bashir MI, Wani AI, Laway BA, Masoodi SR, Ganie MA, Salahuddin M. Clinical and endocrine aspects of thyrotoxicosis and its cardiovascular complications. Ann Saudi Med. 2000, 20:485-7. 10.5144\/0256-4947.2000.485","journal-title":"Ann Saudi Med"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(79)90243-1","article-title":"Occult thyrotoxicosis: a reversible cause of \u201cidiopathic\u201d atrial fibrillation","volume":"44","author":"Forfar JC","year":"1979","unstructured":"Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a reversible cause of \u201cidiopathic\u201d atrial fibrillation. Am J Cardiol. 1979, 44:9-12. 10.1016\/0002-9149(79)90243-1","journal-title":"Am J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6088.688","article-title":"Arterial embolism in thyrotoxicosis with atrial fibrillation","volume":"2","author":"Staffurth JS","year":"1977","unstructured":"Staffurth JS, Gibberd MC, Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J. 1977, 2:688-90. 10.1136\/bmj.2.6088.688","journal-title":"Br Med J"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2003.11.040","article-title":"Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism","volume":"99","author":"Aras D","year":"2005","unstructured":"Aras D, Maden O, Ozdemir O, et al.. Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol. 2005, 99:59-64. 10.1016\/j.ijcard.2003.11.040","journal-title":"Int J Cardiol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.08.018","article-title":"Cardiovascular abnormalities in hyperthyroidism: a prospective doppler echocardiographic study","volume":"118","author":"Merc\u00e9 J","year":"2005","unstructured":"Merc\u00e9 J, Ferr\u00e1s S, Oltra C, et al.. Cardiovascular abnormalities in hyperthyroidism: a prospective doppler echocardiographic study. Am J Med. 2005, 118:126-31. 10.1016\/j.amjmed.2004.08.018","journal-title":"Am J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/50151-frequency-of-cardiovascular-manifestation-in-patients-with-hyperthyroidism","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:00Z","timestamp":1707507180000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/50151-frequency-of-cardiovascular-manifestation-in-patients-with-hyperthyroidism"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,21]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.12839","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,21]]}}}